A detailed history of Kistler Tiffany Companies, LLC transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Kistler Tiffany Companies, LLC holds 1,443 shares of VRTX stock, worth $725,035. This represents 0.08% of its overall portfolio holdings.

Number of Shares
1,443
Previous 1,443 -0.0%
Holding current value
$725,035
Previous $454,000 11.67%
% of portfolio
0.08%
Previous 0.09%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 09, 2022

SELL
$273.83 - $305.53 $51,480 - $57,439
-188 Reduced 11.53%
1,443 $418,000
Q1 2022

May 11, 2022

SELL
$221.42 - $260.97 $25,463 - $30,011
-115 Reduced 6.59%
1,631 $426,000
Q4 2021

Jan 25, 2022

BUY
$177.01 - $223.45 $2,655 - $3,351
15 Added 0.87%
1,746 $383,000
Q3 2021

Nov 10, 2021

BUY
$181.39 - $202.99 $6,167 - $6,901
34 Added 2.0%
1,731 $314,000
Q2 2021

Aug 04, 2021

SELL
$187.49 - $221.1 $69,183 - $81,585
-369 Reduced 17.86%
1,697 $342,000
Q1 2021

May 07, 2021

BUY
$207.02 - $241.31 $131,043 - $152,749
633 Added 44.17%
2,066 $444,000
Q4 2020

Feb 03, 2021

BUY
$207.01 - $276.09 $136,212 - $181,667
658 Added 84.9%
1,433 $339,000
Q3 2020

Nov 03, 2020

BUY
$255.65 - $303.1 $37,836 - $44,858
148 Added 23.6%
775 $211,000
Q2 2020

Jul 20, 2020

SELL
$225.48 - $295.8 $12,626 - $16,564
-56 Reduced 8.2%
627 $182,000
Q3 2019

Oct 18, 2019

BUY
$166.23 - $187.09 $11,469 - $12,909
69 Added 11.24%
683 $116,000
Q2 2019

Jul 22, 2019

BUY
$164.61 - $190.37 $2,139 - $2,474
13 Added 2.16%
614 $113,000
Q2 2018

Jul 17, 2018

SELL
$145.72 - $169.96 $9,034 - $10,537
-62 Reduced 9.35%
601 $102,000
Q1 2018

Apr 06, 2018

BUY
$151.6 - $177.13 $1,970 - $2,302
13 Added 2.0%
663 $108,000
Q4 2017

Jan 11, 2018

SELL
$137.28 - $155.55 $2,059 - $2,333
-15 Reduced 2.26%
650 $97,000
Q3 2017

Oct 19, 2017

BUY
$148.13 - $162.24 $98,506 - $107,889
665
665 $101,000

Others Institutions Holding VRTX

About VERTEX PHARMACEUTICALS INC


  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $129B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Kistler Tiffany Companies, LLC Portfolio

Follow Kistler Tiffany Companies, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kistler Tiffany Companies, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Kistler Tiffany Companies, LLC with notifications on news.